| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00198-004-1809-9 |
| P698 | PubMed publication ID | 15578157 |
| P2093 | author name string | Patrick Ammann | |
| P2860 | cites work | The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis | Q28241336 |
| Importance of preclinical studies in the development of drugs for treatment of osteoporosis: a review related to the 1998 WHO guidelines | Q33767974 | ||
| Sex steroids and the construction and conservation of the adult skeleton | Q34131889 | ||
| Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis | Q34374271 | ||
| Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group | Q34409983 | ||
| The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro | Q34734649 | ||
| The effect on vertebral bone mass and strength of long term treatment with antiresorptive agents (estrogen and calcitonin), human parathyroid hormone-(1-38), and combination therapy, assessed in aged ovariectomized rats | Q36747279 | ||
| Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis | Q37372546 | ||
| New developments in biochemical markers for osteoporosis | Q41282498 | ||
| Bone mineral density reflects bone mass but also the degree of mineralization of bone: therapeutic implications | Q41632573 | ||
| S 12911-2 inhibits osteoclastic bone resorption in vitro | Q42443380 | ||
| Recovery of proximal tibia bone mineral density and strength, but not cancellous bone architecture, after long-term bisphosphonate or selective estrogen receptor modulator therapy in aged rats | Q43855557 | ||
| Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators | Q43988923 | ||
| Long-term treatment with strontium ranelate increases vertebral bone mass without deleterious effect in mice | Q44037465 | ||
| In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation | Q44100791 | ||
| S12911-2 reduces bone loss induced by short-term immobilization in rats | Q44550191 | ||
| Strontium ranelate improves bone resistance by increasing bone mass and improving architecture in intact female rats | Q45146640 | ||
| Strontium increases vertebral bone volume in rats at a low dose that does not induce detectable mineralization defect | Q46293746 | ||
| Bone fragility of the peripheral skeleton during fluoride therapy for osteoporosis. | Q46398557 | ||
| Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group | Q48527134 | ||
| Age, gender, and bone lamellae elastic moduli. | Q54433580 | ||
| An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats. | Q55066319 | ||
| Mechanical properties and biochemical composition of rat cortical femur and tibia after long-term treatment with biosynthetic human growth hormone | Q67840012 | ||
| Fluoride therapy in postmenopausal osteopenic women: Effect on vertebral and femoral bone density and prediction of bone response | Q67857369 | ||
| Increased incidence of hip fracture in osteoporotic women treated with sodium fluoride | Q69623286 | ||
| Safe and effective treatment of osteoporosis with intermittent slow release sodium fluoride: augmentation of vertebral bone mass and inhibition of fractures | Q69934630 | ||
| Bone density and shape as determinants of bone strength in IGF-I and/or pamidronate-treated ovariectomized rats | Q71474639 | ||
| Growth hormone stimulates bone formation and strength of cortical bone in aged rats | Q71549016 | ||
| Strontium distribution and interactions with bone mineral in monkey iliac bone after strontium salt (S 12911) administration | Q71670564 | ||
| High fluoride intakes cause osteomalacia and diminished bone strength in rats with renal deficiency | Q71899873 | ||
| Human parathyroid hormone (1-34) and (1-84) increase the mechanical strength and thickness of cortical bone in rats | Q72600102 | ||
| IGF-I and pamidronate increase bone mineral density in ovariectomized adult rats | Q72603230 | ||
| PTH has a more pronounced effect on vertebral bone mass and biomechanical competence than antiresorptive agents (estrogen and bisphosphonate)--assessed in sexually mature, ovariectomized rats | Q72694705 | ||
| Parathyroid hormone (1-34) and (1-84) stimulate cortical bone formation both from periosteum and endosteum | Q72736598 | ||
| Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women | Q73150132 | ||
| The influence of combined parathyroid hormone and growth hormone treatment on cortical bone in aged ovariectomized rats | Q73226238 | ||
| Heterogeneity of bone lamellar-level elastic moduli | Q73835333 | ||
| Elastic properties of human cortical and trabecular lamellar bone measured by nanoindentation | Q73860814 | ||
| Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women | Q73911971 | ||
| Early effects of short-term parathyroid hormone administration on bone mass, mineral content, and strength in female rats | Q74350822 | ||
| Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: the FAVOStudy | Q74841216 | ||
| Gain in bone mineral mass in prepubertal girls 3.5 years after discontinuation of calcium supplementation: a follow-up study | Q77053463 | ||
| Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents | Q77878009 | ||
| Mechanical and morphological variation of the human lumbar vertebral cortical and trabecular bone | Q77975436 | ||
| Elastic modulus and hardness of cortical and trabecular bone lamellae measured by nanoindentation in the human femur | Q78222157 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | strontium | Q938 |
| P304 | page(s) | S11-5 | |
| P577 | publication date | 2005-01-01 | |
| P1433 | published in | Osteoporosis International | Q7107640 |
| P1476 | title | Strontium ranelate: a novel mode of action leading to renewed bone quality | |
| P478 | volume | 16 Suppl 1 |
| Q43159591 | A novel method for local administration of strontium from implant surfaces |
| Q39442485 | A physiologically based pharmacokinetic model for strontium exposure in rat. |
| Q36752277 | Anabolic agents and the bone morphogenetic protein pathway |
| Q51734259 | Applications of Metals for Bone Regeneration. |
| Q63991062 | Cylindrical Layered Bone Scaffolds with Anisotropic Mechanical Properties as Potential Drug Delivery Systems |
| Q34727815 | Efficacy of strontium ranelate in combination with a D-hormone analog for the treatment of postmenopausal osteoporosis |
| Q64237704 | In vitro cellular testing of strontium/calcium substituted phosphate glass discs and microspheres shows potential for bone regeneration |
| Q83348229 | In vitro study in stimulating the secretion of angiogenic growth factors of strontium-doped calcium polyphosphate for bone tissue engineering |
| Q39737232 | Osteopenic bone cell response to strontium-substituted hydroxyapatite |
| Q34340868 | Strontium is incorporated in different levels into bones and teeth of rats treated with strontium ranelate |
| Q57162867 | Strontium ranelate changes the composition and crystal structure of the biological bone-like apatite produced in osteoblast cell cultures |
| Q37300106 | Strontium ranelate improves the interaction of osteoblastic cells with titanium substrates: Increase in cell proliferation, differentiation and matrix mineralization |
| Q39138461 | Strontium ranelate increases the formation of bone-like mineralized nodules in osteoblast cell cultures and leads to Sr incorporation into the intact nodules |
| Q31033939 | Strontium ranelate--data on vertebral and nonvertebral fracture efficacy and safety: mechanism of action |
| Q39437837 | Study on bio-corrosion and cytotoxicity of a sr-based bulk metallic glass as potential biodegradable metal. |
| Q35651890 | The changes in bone organic and inorganic matrix in newborn rats after maternal application of antiretroviral agents: Indinavir and zidovudine |
| Q34067224 | The differences of femoral neck geometric parameters: effects of age, gender and race. |
Search more.